Prevalence of ATLI in patients according to acetylator status.

#<p>Cochrane-Armitage test for trend.</p

Definition of acetylator status according to NAT2 genotypes.

<p>Definition of acetylator status according to NAT2 genotypes.</p

Characteristics of patients.

<p>Characteristics of patients.</p

Prevalence of ATLI by NAT genotype.

<p>Prevalence of ATLI by NAT genotype.</p

Incidence of ATLI in patients tested at 2 months.

1<p>ALT, AST or bilirubin more than twice the upper limit of the normal range.</p>2<p>ALT, AST or bilirubin above the upper limit of the normal range and less than twice the upper limit of normal.</p>3<p>ALT, AST and bilirubin within the normal range.</p

Prevalence of ATLI according to N-acetyltransferase 2 (NAT2) genotype.

#<p>Cochrane-Armitage test.</p

Genetic polymorphisms of CYP2E1,GSTM1 and GSTT1 and the prevalence of ATLI.

*<p>Cochrane-Armitage test.</p